CanSino Biologics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
25.00
-395.00
-2,188.00
-1,376.00
2,334.00
-445.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-178.00
-125.00
-161.00
-1,719.00
101.00
-113.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
36.00
-251.00
-1,077.00
-2,125.00
2,466.00
-502.00
Cash Flow from Investing Activities
395.00
4.00
-487.00
-1,510.00
-2,376.00
-237.00
Cash Flow from Financing Activities
-782.00
-293.00
69.00
1,048.00
1,168.00
5,540.00
Net Cash Inflow / Outflow
-364.00
-531.00
-1,474.00
-2,400.00
1,216.00
4,769.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-14.00
9.00
22.00
186.00
-40.00
-30.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CanSino Biologics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
25.0806874713922
19.3981615355217
6.00
29.29%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-178.091751753535
-61.8306645243257
-117.00
-188.03%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
36.167769890316
273.142656697882
-237.00
-86.76%
Cash Flow from Investing Activities
395.638463734055
-330.018440862169
725.00
219.88%
Cash Flow from Financing Activities
-782.70919283938
-29.4327696347497
-753.00
-2559.31%
Net Cash Inflow / Outflow
-364.981157090393
-70.9679320859089
-294.00
-414.29%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-14.0781978753845
15.3406217131278
-29.00
-191.77%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 114.37% vs 76.64% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
36.17
-251.75
114.37%






